News and Announcements
YPB On Track for Step Change in Profitability
- Published September 06, 2016 10:08AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
31st August 2016, ASX Announcement
- Half year loss in line with expectations
- Substantial progress in business development to become apparent later in H2 20216
- A strong acceleration in revenue to commence in Q4 2016
- Costs being judiciously controlled
- Expectations of breakeven Q1 2017 and FY17 EBT of $5m reconfirmed
Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) is pleased to announce its financial results for the year ended 30 June 2016.
The period was pivotal for the company as it launched commercialisation of its end-to-end Anti-Counterfeit and Customer Engagement solutions suite. Significant development of the business was achieved in the half year although that progress was not yet visible in the financial results.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
